BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
is a new organisation to improve the process of developing and testing new medicines. Its objective is to make the way that new medicines are tested more efficient and more cost effective.
ï· As part of its offering to customers in the life sciences sector it will develop a trials management platform that integrates the end-to-end process from trial design to data analysis and reporting.
ï· Once Protas has defined its specification for the trials management platform, it will undertake a procurement process to identify an infrastructure provider to produce (and operate) the IT platform on behalf of Protas. The IT platform will need to be configurable, modular, scaleable and re-useable.
ï· The purpose of this RfP exercise is to appoint a technical consultancy to assist Protas in developing and refining Protas's specification for the design and technical architecture for the IT platform. The deliverable will be a detailed technical requirements specification for the IT platform for use in the subsequent procurement process for an infrastructure provider.
ï· The technical consultancy should have relevant expertise in the design and technical architecture of comparable systems, the ability to incorporate existing systems and applications as well as undertaking specific coding development, expertise in data ingress and egress, communications networks, cloud strategy, security and data standards for health data and the ability to define the interoperability of the different off-the-shelf components.
ï· Details of the process for selecting a technical consultancy to support Protas in this phase of work are included in the procurement document.
Responses should be by e-mail to the contact listed in the RfP no later than the time specified
No supplier information available.